Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Multiple electrode aggregometry in antiplatelet-related intracerebral haemorrhage.

Beynon C, Sakowitz OW, Unterberg AW.

J Clin Neurosci. 2013 Dec;20(12):1805-6. doi: 10.1016/j.jocn.2013.02.022. Epub 2013 Jul 5.

PMID:
23830689
2.

Initial experiences with Multiplate® for rapid assessment of antiplatelet agent activity in neurosurgical emergencies.

Beynon C, Scherer M, Jakobs M, Jung C, Sakowitz OW, Unterberg AW.

Clin Neurol Neurosurg. 2013 Oct;115(10):2003-8. doi: 10.1016/j.clineuro.2013.06.002. Epub 2013 Jul 2.

PMID:
23830497
3.

An assessment of cardiopulmonary bypass-induced changes in platelet function using whole blood and classical light transmission aggregometry: the results of a pilot study.

Velik-Salchner C, Maier S, Innerhofer P, Kolbitsch C, Streif W, Mittermayr M, Praxmarer M, Fries D.

Anesth Analg. 2009 Jun;108(6):1747-54. doi: 10.1213/ane.0b013e3181a198ac.

PMID:
19448196
4.

Combined anti-platelet therapy with aspirin and clopidogrel: risk factor for thrombolysis-related intracerebral hemorrhage in acute ischemic stroke?

Hermann A, Dzialowski I, Koch R, Gahn G.

J Neurol Sci. 2009 Sep 15;284(1-2):155-7. doi: 10.1016/j.jns.2009.05.003. Epub 2009 May 26.

PMID:
19473668
6.

Impact of platelet transfusion on hematoma expansion in patients receiving antiplatelet agents before intracerebral hemorrhage.

Ducruet AF, Hickman ZL, Zacharia BE, Grobelny BT, DeRosa PA, Landes E, Lei S, Khandji J, Gutbrod S, Connolly ES Jr.

Neurol Res. 2010 Sep;32(7):706-10. doi: 10.1179/174313209X459129.

PMID:
20819399
7.

Aspirin and clopidogrel resistance: an emerging clinical entity.

Wang TH, Bhatt DL, Topol EJ.

Eur Heart J. 2006 Mar;27(6):647-54. Epub 2005 Dec 19. Review.

PMID:
16364973
8.

Usefulness of monitoring platelet function by multiple electrode aggregometry in primary coronary artery bypass surgery.

Mengistu AM, Mayer J, Boldt J, Röhm KD, Suttner SW.

J Cardiothorac Vasc Anesth. 2011 Feb;25(1):42-7. doi: 10.1053/j.jvca.2010.02.008. Epub 2010 Apr 27. Retraction in: J Cardiothorac Vasc Anesth. 2011 Aug;25(4):755-7.

PMID:
20427204
9.

Clopidogrel hyper-response and bleeding risk in neurointerventional procedures.

Goh C, Churilov L, Mitchell P, Dowling R, Yan B.

AJNR Am J Neuroradiol. 2013 Apr;34(4):721-6. doi: 10.3174/ajnr.A3418. Epub 2012 Dec 28.

10.

Aspirin and clopidogrel: a sweeping combination in cardiology.

Manolis AS, Tzeis S, Andrikopoulos G, Koulouris S, Melita H.

Curr Med Chem Cardiovasc Hematol Agents. 2005 Jul;3(3):203-19. Review.

PMID:
15974885
11.

Prevalence of ex vivo high on-treatment platelet reactivity on antiplatelet therapy after transient ischemic attack or ischemic stroke on the PFA-100(®) and VerifyNow(®).

Kinsella JA, Tobin WO, Cox D, Coughlan T, Collins R, O'Neill D, Murphy RP, McCabe DJ.

J Stroke Cerebrovasc Dis. 2013 Oct;22(7):e84-92. doi: 10.1016/j.jstrokecerebrovasdis.2012.07.012. Epub 2012 Sep 13.

PMID:
22981273
12.

[Platelet responsiveness to clopidogrel in patients with coronary syndrome. Comparison of platelet aggregation induced by ADP and flow cytometric analysis of intraplatelet VASP phosphorylation].

Morel O, Viellard C, Faure A, Jesel L, Ohlmann P, Desprez D, Chauvin M, Roul G, Grunebaum L, Bareiss P.

Ann Cardiol Angeiol (Paris). 2007 Jan;56(1):21-9. French.

PMID:
17343035
13.

Dual antiplatelet therapy and heparin "bridging" significantly increase the risk of bleeding complications after pacemaker or implantable cardioverter-defibrillator device implantation.

Tompkins C, Cheng A, Dalal D, Brinker JA, Leng CT, Marine JE, Nazarian S, Spragg DD, Sinha S, Halperin H, Tomaselli GF, Berger RD, Calkins H, Henrikson CA.

J Am Coll Cardiol. 2010 May 25;55(21):2376-82. doi: 10.1016/j.jacc.2009.12.056.

14.

Antiplatelet effects of angiotensin-converting enzyme inhibitors compared with aspirin and clopidogrel: a pilot study with whole-blood aggregometry.

Bauriedel G, Skowasch D, Schneider M, Andrié R, Jabs A, Lüderitz B.

Am Heart J. 2003 Feb;145(2):343-8.

PMID:
12595854
15.

Factors influencing multiplate whole blood impedance platelet aggregometry measurements, during aspirin treatment in acute ischemic stroke: a pilot study.

Jastrzębska M, Chełstowski K, Wódecka A, Siennicka A, Clark J, Nowacki P.

Blood Coagul Fibrinolysis. 2013 Dec;24(8):830-8. doi: 10.1097/MBC.0b013e3283655640.

PMID:
24071649
16.

Short-term effects of aspirin and clopidogrel on mean platelet volume among patients with acute coronary syndromes. A single-center prospective study.

De Luca G, Secco GG, Iorio S, Verdoia M, Bellomo G, Marino P.

Blood Coagul Fibrinolysis. 2012 Dec;23(8):756-9. doi: 10.1097/MBC.0b013e328358e941.

PMID:
23135381
17.

Maintenance of perioperative antiplatelet and anticoagulant therapy for vitreoretinal surgery.

Ryan A, Saad T, Kirwan C, Keegan DJ, Acheson RW.

Clin Exp Ophthalmol. 2013 May-Jun;41(4):387-95. doi: 10.1111/ceo.12017. Epub 2012 Dec 10.

PMID:
23094982
18.

Indications for dual antiplatelet therapy with aspirin and clopidogrel: evidence-based recommendations for use.

Reaume KT, Regal RE, Dorsch MP.

Ann Pharmacother. 2008 Apr;42(4):550-7. doi: 10.1345/aph.1K433. Epub 2008 Mar 4. Review.

PMID:
18319394
19.

Possibility of a rebound phenomenon following antiplatelet therapy withdrawal: a look at the clinical and pharmacological evidence.

Lordkipanidzé M, Diodati JG, Pharand C.

Pharmacol Ther. 2009 Aug;123(2):178-86. doi: 10.1016/j.pharmthera.2009.03.019. Epub 2009 May 6. Review.

PMID:
19426760
20.

Influence of oral antiplatelet therapy on hemorrhagic complications of pacemaker implantation.

Said SM, Esperer HD, Hahn J, Bollmann A, Richter S, Rauwolf T, Prondzinsky R, Schmeisser A, Braun-Dullaeus RC.

Clin Res Cardiol. 2013 May;102(5):345-9. doi: 10.1007/s00392-013-0543-8. Epub 2013 Feb 6.

PMID:
23386254

Supplemental Content

Support Center